{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:19:19Z","timestamp":1790720359641,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.biocel.2014.01.020","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T02:16:17Z","timestamp":1391393777000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"special_numbering":"C","title":["Coenzyme Q10 as a therapy for mitochondrial disease"],"prefix":"10.1016","volume":"49","author":[{"given":"I.P.","family":"Hargreaves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2014.01.020_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-510X(98)00296-2","article-title":"Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): evaluation by noninvasive tissue oximetry","volume":"162","author":"Abe","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.biocel.2014.01.020_bib0440","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0003-9861(92)90511-T","article-title":"Distribution and redox state of ubiquinones in rat and human tissues","volume":"295","author":"Aberg","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.biocel.2014.01.020_bib0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ana.410190615","article-title":"Treatment of mitochondrial myopathy due to complex III deficiency with vitamins KE3 and C: a 31P NMR follow-up study","volume":"19","author":"Argov","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1096\/fj.02-1022fje","article-title":"Silencing of ubiquinone biosynthesis genes extends life span in Caenorhabditis elegans","volume":"17","author":"Asencio","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.biocel.2014.01.020_bib0020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1212\/01.WNL.0000134607.76780.B2","article-title":"Progressive despite resplacement of a myopathic form of coenzyme Q10 deficiency","volume":"63","author":"Aure","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2014.01.020_bib0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/biof.5520090221","article-title":"Improved brain and muscle mitochondrial respiration with CoQ. An in vivo study by 31P-MR spectroscopy in patients with mitochondrial cytopathies","volume":"9","author":"Barbiroli","year":"1999","journal-title":"Biofactors"},{"key":"10.1016\/j.biocel.2014.01.020_bib0445","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1152\/ajpcell.00195.2006","article-title":"Physiological diversity of mitochondrial oxidative phosphorylation","volume":"29","author":"Benard","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0030","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.42.6.1203","article-title":"31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies","volume":"42","author":"Bendahan","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2014.01.020_bib0035","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.mito.2007.02.006","article-title":"The antioxidant role of coenzyme Q","volume":"7S","author":"Bentinger","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biocel.2014.01.020_bib0045","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.mito.2007.03.003","article-title":"Plasma coenzyme Q10 response to oral ingesti\u00f3n of coenzyme Q10 formulations","volume":"7S","author":"Bhagavan","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biocel.2014.01.020_bib0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0076-6879(04)78008-8","article-title":"Extramitochondrial reduction by flavoenzymes","volume":"378","author":"Bjornstedt","year":"2004","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0450","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00228-008-0596-1","article-title":"Pharmacokinetics and metabolism of idebenone in healthy male subjects","volume":"65","author":"Bodmer","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0055","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bbrc.2004.03.002","article-title":"Quinone analogues regulate mitochondrial substrate competitive oxidation","volume":"316","author":"Briere","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biocel.2014.01.020_bib0060","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/WNL.38.6.892","article-title":"Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10","volume":"38","author":"Bresolin","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2014.01.020_bib0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0022-510X(90)90015-F","article-title":"Ubidecarenone in the treatment of mitochondrial myopathies: a multicentre double-blind trial","volume":"10","author":"Bresolin","year":"1990","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.biocel.2014.01.020_bib0075","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s004150050267","article-title":"Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy","volume":"245","author":"Chan","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1196\/annals.1293.023","article-title":"Mitochondrial encephalomyopathies: therapeutic approach","volume":"1011","author":"Dimauro","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biocel.2014.01.020_bib0090","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1373\/clinchem.2005.054643","article-title":"Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle and plasma by HPLC with a di-propoxy-coenzyme Q10 as an internal standard","volume":"51","author":"Duncan","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.biocel.2014.01.020_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10545-012-9511-0","article-title":"Human neuronal coenzyme Q10 deficiency results in a global loss of mitochondrial respiratory chain activity, increased mitochondrial oxidative stress and a reversal of ATP synthase activity: implications for the pathogenesis and treatment","volume":"36","author":"Duberley","year":"2013","journal-title":"Inherit Metab Dis"},{"key":"10.1016\/j.biocel.2014.01.020_bib0100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2012.206","article-title":"Heterogeneity of coenzyme Q10 deficiency: patient study and literature review","volume":"69","author":"Emmanuele","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0105","first-page":"1868","article-title":"Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial","volume":"165","author":"Engelsen","year":"2003","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.biocel.2014.01.020_bib0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2011.10.009","article-title":"Initial experience in the treatment of inherited mitochondrial disease with EPI-743","volume":"105","author":"Enns","year":"2012","journal-title":"Molec Genet Metab"},{"key":"10.1016\/j.biocel.2014.01.020_bib0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0925-4439(95)00028-3","article-title":"Biochemical, physiological and medical aspects of ubiquinone function","volume":"1271","author":"Ernster","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biocel.2014.01.020_bib0120","first-page":"5","article-title":"Biochemical, physiological and medical aspects of ubiquinone function","volume":"1271","author":"Ernster","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biocel.2014.01.020_bib0125","first-page":"380","article-title":"Ubiquinol: an endogenous antioxidant in aerobic organisms","volume":"40","author":"Ernster","year":"1993","journal-title":"Clin Invest"},{"key":"10.1016\/j.biocel.2014.01.020_bib0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2008-1040954","article-title":"Clinical spectrum of mitochondrial diseases","volume":"16","author":"Fadic","year":"1996","journal-title":"Semin Neurol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.112.195586","article-title":"Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cells","volume":"342","author":"Fink","year":"2012","journal-title":"JPET"},{"key":"10.1016\/j.biocel.2014.01.020_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1096-7192(02)00145-2","article-title":"Coenzyme Q (10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits","volume":"77","author":"Geromel","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.biocel.2014.01.020_bib0455","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbabio.2011.10.012","article-title":"The effects of idebenone on mitocondrial bioenergetics","volume":"1817","author":"Giorgio","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biocel.2014.01.020_bib0155","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mus.21758","article-title":"A randomized trial of coenzyme Q10 in mitochondrial disorders","author":"Glover","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.biocel.2014.01.020_bib0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00314013","article-title":"Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy","volume":"234","author":"Goda","year":"1987","journal-title":"J Neurol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0170","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1542\/peds.2007-0391","article-title":"Mitochondrial disease: a practical approach for primary care physicians","volume":"120","author":"Haas","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.biocel.2014.01.020_bib0175","doi-asserted-by":"crossref","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","article-title":"NQO1-dependent redox cycling of idebenone: effects on cellular redox potencial and energy levels","volume":"6","author":"Haefeli","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2014.01.020_bib0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2008.11.008","article-title":"Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study","volume":"278","author":"Haginoya","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.biocel.2014.01.020_bib0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1258\/000456303321610493","article-title":"Ubiquinone: cholesterol's reclusive cousin","volume":"40","author":"Hargreaves","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.biocel.2014.01.020_bib0190","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2165\/00002018-200528080-00002","article-title":"The effect of HMG-CoA reductase inhibitors on coenzyme Q10","volume":"28","author":"Hargreaves","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.biocel.2014.01.020_bib0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-005-4160-1","article-title":"Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment","volume":"28","author":"Hargreaves","year":"2005","journal-title":"J Inherit Metab"},{"key":"10.1016\/j.biocel.2014.01.020_bib0200","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/WCO.0b013e32833d1096","article-title":"Mitochondrial myopathies: developments in treatment","volume":"23","author":"Hassani","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0205","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1172\/JCI45693","article-title":"COQ6 mutations cause nephrotic syndrome with sensorineural deafness in humans, concurrent with increased apoptosis","volume":"121","author":"Heeringa","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biocel.2014.01.020_bib0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/biof.5520320124","article-title":"Safety assessment of coenzyme Q10 (CoQ10)","volume":"32","author":"Hidaka","year":"2008","journal-title":"Biofactors"},{"key":"10.1016\/j.biocel.2014.01.020_bib0215","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.47.2.583","article-title":"Idebenone improves cerebral mitocondrial oxidative metabolismo in a patient with MELAS","volume":"47","author":"Ikejiri","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2014.01.020_bib0220","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.mad.2005.03.026","article-title":"Mitochondria-targeted redox robes as tools in the study of oxidative damage and aging","volume":"126","author":"James","year":"2005","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.biocel.2014.01.020_bib0225","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13311-013-0176-7","article-title":"Review of clinical trials for mitochondrial disorder: 1997\u20132012","volume":"10","author":"Kerr","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biocel.2014.01.020_bib0230","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1167\/iovs.08-3166","article-title":"Quality of life in patients with leber hereditary optic neuropathy","volume":"50","author":"Kirkman","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biocel.2014.01.020_bib0235","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.biocel.2014.01.020_bib0240","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0891-5849(02)00916-4","article-title":"Effects of coenzyme Q10 administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat","volume":"33","author":"Kwong","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.biocel.2014.01.020_bib0245","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s11064-006-9222-8","article-title":"Some observations upon biochemical causes of ataxia and a new disease entity, CoQ10 deficiency","volume":"32","author":"Land","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biocel.2014.01.020_bib0250","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1023\/B:NERE.0000014819.53972.b0","article-title":"Mitochondrial disease: a historical, biochemical, and London perspective","volume":"29","author":"Land","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biocel.2014.01.020_bib0255","first-page":"3226","article-title":"Interaction between warfarin and coenzyme Q10","volume":"160","author":"Landbo","year":"1998","journal-title":"Ugwskr Laeger"},{"key":"10.1016\/j.biocel.2014.01.020_bib0260","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1328-0163(98)90022-7","article-title":"Coenzyme Q10 in cardiovascular disease with special emphasis on heart failure and myocardial ischemia","volume":"7","author":"Langsjoen","year":"1998","journal-title":"Asia Pacific Heart J"},{"key":"10.1016\/j.biocel.2014.01.020_bib0265","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1126\/science.1230381","article-title":"Supercomplex assembly determines electron flux in the mitocondrial electron transport chain","volume":"340","author":"Lapuente-Brun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biocel.2014.01.020_bib0270","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0891-5849(99)00085-4","article-title":"Comparisons of coenzymevQ bound to mitochondrial membrane proteins among different mammalian species","volume":"27","author":"Lass","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.biocel.2014.01.020_bib0275","doi-asserted-by":"crossref","first-page":"e11897","DOI":"10.1371\/journal.pone.0011897","article-title":"Treatment of CoQ10 deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects","volume":"5","author":"Lopez","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2014.01.020_bib0280","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/hmg\/ddm058","article-title":"Missense mutation of the CoQ2 gene causes defects of bioenergetics and defects of bioenergetics and de novo pyrimidine synthesis","volume":"16","author":"Lopez-Martin","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biocel.2014.01.020_bib0285","first-page":"619","article-title":"Nutritional and exercise-based therapies in the treatment of mitochondrial disease","volume":"5","author":"Mahoney","year":"2002","journal-title":"Curr Opin Clin Nutr Metabol Care"},{"key":"10.1016\/j.biocel.2014.01.020_bib0290","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","article-title":"Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects","volume":"95","author":"Mathews","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2014.01.020_bib0295","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ymgme.2012.09.007","article-title":"EPI-743 reverses the progrssion of the pediatric mitochondrial disease","volume":"107","author":"Martinelli","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.biocel.2014.01.020_bib0300","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0960-8966(91)90007-F","article-title":"Muscle coenzyme Q10 in mitocondrial encephalomyopathies","volume":"1","author":"Matsuoka","year":"1991","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.biocel.2014.01.020_bib0305","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1212\/WNL.43.5.884","article-title":"Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease","volume":"43","author":"Matthews","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2014.01.020_bib0310","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.mito.2008.01.003","article-title":"Systemic evaluation of muscle coenzyme Q10 content in children with mitochondrial respiratory chain enzyme deficiencies","volume":"8","author":"Miles","year":"2008","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biocel.2014.01.020_bib0315","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1056\/NEJMc0800582","article-title":"Early supplementation in primary coenzyme Q10 deficiency","volume":"358","author":"Montini","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biocel.2014.01.020_bib0320","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/biof.5520250112","article-title":"Muscle coenzyme Q10 concentrations in patients with a probable and definitive diagnosis of respiratory chain disorders","volume":"25","author":"Montero","year":"2005","journal-title":"Biofactors"},{"key":"10.1016\/j.biocel.2014.01.020_bib0325","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.clinbiochem.2008.03.007","article-title":"Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes","volume":"41","author":"Montero","year":"2008","journal-title":"Clin Biochem."},{"key":"10.1016\/j.biocel.2014.01.020_bib0460","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mito.2013.04.001","article-title":"Coenzyme Q10 deficiency in mitocondrial DNA depletion s\u00edndromes","volume":"13","author":"Montero","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biocel.2014.01.020_bib0330","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1056\/NEJMc0800582","article-title":"Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency","volume":"358","author":"Montini","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biocel.2014.01.020_bib0335","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1212\/WNL.39.3.399","article-title":"Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study","volume":"39","author":"Nishikawa","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2014.01.020_bib0340","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1073\/pnas.86.7.2379","article-title":"Muscle coenzymee Q deficiency in familial mitocondrial encephalomyopathy","volume":"86","author":"Ogasahara","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2014.01.020_bib0345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/WNL.36.1.45","article-title":"Treatment of Kearns\u2013Sayre syndrome with coenzyme Q10","volume":"36","author":"Ogasahara","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2014.01.020_bib0350","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1212\/WNL.35.3.372","article-title":"Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns\u2013Sayre syndrome","volume":"35","author":"Ogasahara","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2014.01.020_bib0355","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0960-8966(95)00020-8","article-title":"The influence of coenzyme Q10 on total serum calcium concentration in two patients with Kearns\u2013Sayre syndrome and hypoparathyroidism","volume":"6","author":"Papadimitriou","year":"1996","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.biocel.2014.01.020_bib0390","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High dose statins and skeletal muscle metabolism in humans: a randomized controlled trial","volume":"78","author":"P\u00e4iv\u00e4","year":"2005","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.biocel.2014.01.020_bib0395","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jacl.2013.02.002","article-title":"A randomized trial of coenzyme Q10 in patients with statin myopathy: rationale and study design","volume":"7","author":"Parker","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0360","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/biof.5520250109","article-title":"Life-long supplementation with a low dosage of coenzyme Q10 in the rat: effects on antioxidant status and DNA damage","volume":"25","author":"Quiles","year":"2005","journal-title":"Biofactors"},{"key":"10.1016\/j.biocel.2014.01.020_bib0365","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11064-006-9190-z","article-title":"Human coenzyme Q10 deficiency","volume":"32","author":"Quinzii","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biocel.2014.01.020_bib0370","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nmd.2011.05.001","article-title":"176TH ENMC International Workshop: diagnosis and treatment of coenzyme Q10 deficiency","volume":"22","author":"Rahman","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.biocel.2014.01.020_bib0375","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jnnp.2008.158279","article-title":"Mitochondrial diseases disorders: diagnosis and new treatments in mitochondrial disease","volume":"80","author":"Rahman","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biocel.2014.01.020_bib0465","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/WNO.0b013e318272c643","article-title":"Effects of idebenone on color vision in patients with Leber hereditary optic neuropathy","volume":"33","author":"Rudolph","year":"2013","journal-title":"J Neuro-Ophthalmol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0380","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","article-title":"Animal and human studies with the mitochondria-targeted antioxidant mitoQ","volume":"1201","author":"Smith","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biocel.2014.01.020_bib0400","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.mito.2007.02.008","article-title":"Infantile and pediatric quinone deficiency diseases","volume":"7S","author":"Rotig","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biocel.2014.01.020_bib0405","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nmd.2009.10.014","article-title":"Coenzyme Q10 is frequently reduced in muscle of patients with mitocondrial myopathy","volume":"20","author":"Sacconi","year":"2010","journal-title":"Neuromuscular Disorders"},{"key":"10.1016\/j.biocel.2014.01.020_bib0410","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archneurol.2011.2972","article-title":"Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy","volume":"69","author":"Sadun","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biocel.2014.01.020_bib0415","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1073\/pnas.86.20.7952","article-title":"Spontaneous Kearns\u2013Sayre\/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy","volume":"86","author":"Shoffner","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2014.01.020_bib0420","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2006.03.004","article-title":"Dose ranging and efficacy study of high dose coenzyme Q10 formulations in Huntington's disease","volume":"1762","author":"Smith","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biocel.2014.01.020_bib0425","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.mito.2007.03.006","article-title":"Coenzyme Q, oxidative stress and aging","volume":"7S","author":"Sohal","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biocel.2014.01.020_bib0430","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.mito.2012.09.005","article-title":"Design and implementation of the first randomized controlled trial of coenzyme Q10 in children with primary mitochondrial disease","volume":"12","author":"Stacpole","year":"2012","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biocel.2014.01.020_bib0470","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbamem.2003.11.012","article-title":"Metabolism and function of coenzyme Q","volume":"1660","author":"Turunen","year":"2004","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.biocel.2014.01.020_bib0435","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00314404","article-title":"Coenzyme Q in serum and muscle of 5 patients with Kearns\u2013Sayre syndrome and 12 patients with ophthalmoplegia plus","volume":"236","author":"Zierz","year":"1989","journal-title":"J Neurol"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272514000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272514000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:52:38Z","timestamp":1761202358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272514000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":87,"alternative-id":["S1357272514000375"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2014.01.020","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coenzyme Q10 as a therapy for mitochondrial disease","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2014.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}